Christopher R. Flowers, MD, ACTSI investigator, associate professor, Department of Hematology and Medical Oncology, Emory University School of Medicine, and director, Emory Lymphoma Program, Winship Cancer Institute
Science Daily | New Drug Shows Promise in Treating Indolent Non-Hodgkin Lymphomas
January 22, 2014
Flowers is PI on the trial PCI-32765DBL3001: A Randomized, Double-blind, Placebo-controlled Phase III Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, PCI-32765 (Ibrutinib), in Combination with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Subjects With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma
US News & World Report | Columbus Dispatch | Englemed Health News | Live Sicence | Science Codex| Central Valley Business Times | Daily Rx | Innovations Report| Mapping a link between blood cancer, industrial pollutant in Georgia
July 29, 2013
Medical News Today | African Americans with blood cancer do not live as long as caucasians, despite equal care
July 8, 2013
Herald Online.com| CLL diagnosis and treatment update
August 23, 2012
In 2013, Henry Young, PhD joined the University of Georgia (UGA) as the Kroger Associate Professor in Community Pharmacy. For the Georgia Clinical & Translational Science Alliance (Georgia CTSA) he is a co-director of the Integrating Special...
